GO:0042060 wound healing: Cellular Mechanisms, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0042060 wound healing is the biological process that restores tissue integrity after injury through coordinated hemostasis, inflammation, proliferation, and remodeling.
• The process depends on dynamic crosstalk among keratinocytes, fibroblasts, endothelial cells, immune cells, and stem cells, orchestrated by growth factors and extracellular matrix signals.
• Dysregulation of wound healing underlies chronic non-healing wounds, excessive scarring, fibrosis, and impaired tissue regeneration in aging and diabetes.
• Key genes and proteins include COL1A1, COL3A1, FN1, TGFB1, VEGFA, PDGFB, MMP2, MMP9, TIMP1, ACTA2, KRT14, and HIF1A, which are frequent targets for functional studies.
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal testing of wound healing genes in keratinocytes, fibroblasts, and endothelial cells.
• Nutritional status, aging, and microbial balance are recognized modifiers of wound healing outcomes and are active areas of translational research.
Description
GO:0042060 wound healing is defined in the Gene Ontology as the series of events that restore integrity to a damaged tissue following an injury. This biological process is fundamental to organismal survival and encompasses a highly coordinated sequence of cellular and molecular responses, including hemostasis, inflammation, proliferation, and tissue remodeling. Researchers study wound healing to understand not only normal tissue repair but also the pathological states that arise when this process is impaired, such as chronic ulcers, fibrosis, and excessive scarring. The clinical burden of non-healing wounds is substantial, particularly in aging populations and in patients with diabetes or vascular disease, making wound healing a priority area for mechanistic and translational investigation. At the cellular level, wound healing requires the spatial and temporal coordination of keratinocytes, fibroblasts, endothelial cells, and immune cells, all of which respond to growth factors, cytokines, and extracellular matrix cues. Consequently, the process is a rich source of therapeutic targets and a benchmark for testing gene function using modern genome-editing technologies.
wound healing At A Glance
| GO ID | GO:0042060 |
|---|---|
| GO term | wound healing |
| Ontology | biological_process |
| Synonym | none |
| Definition | The series of events that restore integrity to a damaged tissue, following an injury. |
| Major function | Coordinated restoration of tissue integrity after injury through hemostasis, inflammation, proliferation, and remodeling. |
| Key cell types | Keratinocytes, fibroblasts, endothelial cells, macrophages, neutrophils, platelets. |
| Major signaling mediators | TGFB1, VEGFA, PDGFB, FGF2, IL-6, TNF, MMPs, TIMPs. |
| Pathological outcomes | Chronic non-healing wounds, fibrosis, hypertrophic scarring, impaired regeneration in aging. |
What Is GO:0042060?
In the context of the Gene Ontology, GO:0042060 wound healing refers to the entire set of biological events that re-establish tissue integrity after damage. This includes the immediate response to injury, the recruitment of immune cells, the proliferation and migration of tissue-forming cells, the deposition of new extracellular matrix, and the subsequent remodeling that restores tissue architecture and function. The term is intentionally broad, covering overlapping and sequential phases rather than a single molecular pathway, and it applies to multiple tissue types and injury models.
Why Is wound healing Important in Cell Biology?
Wound healing is essential for survival because it protects against infection, restores barrier function, and limits blood loss after injury. When this process fails or becomes dysregulated, the consequences range from chronic ulcers and severe scarring to fibrosis and impaired tissue regeneration, all of which impose significant morbidity and healthcare costs. Understanding the molecular and cellular drivers of wound healing is therefore critical for developing targeted therapies and for interpreting how genetic variation affects repair capacity.
• Restores tissue integrity and barrier function after injury, preventing infection and fluid loss.
• Coordinates hemostasis, inflammation, proliferation, and remodeling in a time-dependent manner.
• Involves multiple cell types including keratinocytes, fibroblasts, endothelial cells, and immune cells.
• Dysregulation leads to chronic wounds, which are a major complication of diabetes and vascular disease.
• Excessive or prolonged healing can cause fibrosis and hypertrophic scarring.
• Aging impairs wound healing through changes in skin structure, immune function, and stem cell activity.
• Nutritional status, including protein, vitamin, and mineral availability, modulates healing outcomes.
• Microbial balance and probiotic interventions are emerging as modulators of wound repair.
• Wound healing genes are frequent targets for CRISPR-based functional studies in dermatology and regenerative medicine.
• The process serves as a model for understanding tissue regeneration and fibrosis across organs.
What Happens During wound healing?
Hemostasis and Immediate Response
In simple terms: When you get a cut, your body first stops the bleeding by forming a clot.
Immediately after injury, blood vessels constrict and platelets aggregate to form a fibrin clot, which serves as a provisional matrix. This hemostatic phase releases growth factors and cytokines that recruit inflammatory cells to the wound site. The clot also provides a scaffold for migrating cells and helps to limit blood loss and microbial invasion.
Inflammation and Immune Cell Recruitment
In simple terms: Immune cells arrive to clean the wound and fight germs.
Neutrophils and macrophages infiltrate the wound within hours to days, removing debris, bacteria, and damaged tissue. These cells secrete pro-inflammatory cytokines such as IL-6 and TNF, which amplify the immune response and stimulate subsequent repair phases. Macrophages later transition to a pro-reparative phenotype that supports tissue formation and resolution of inflammation.
Proliferation and Granulation Tissue Formation
In simple terms: New tissue is built to fill the wound gap.
Fibroblasts migrate into the wound and synthesize extracellular matrix components, including collagen I and III, fibronectin, and proteoglycans, forming granulation tissue. Endothelial cells proliferate and form new blood vessels in a process called angiogenesis, which is driven by VEGFA and other angiogenic factors. Keratinocytes at the wound edge proliferate and migrate to re-epithelialize the surface, restoring the epidermal barrier.
Remodeling and Scar Maturation
In simple terms: The new tissue is reorganized and strengthened over time.
During remodeling, the initially deposited collagen III is gradually replaced by collagen I, and matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) regulate matrix turnover. Myofibroblasts, characterized by ACTA2 expression, contract the wound and contribute to scar formation. This phase can last for months to years and determines the final tensile strength and appearance of the repaired tissue.
Resolution and Regeneration
In simple terms: The healing process winds down and normal tissue function is restored as much as possible.
Successful wound healing concludes with the resolution of inflammation, apoptosis of excess cells, and restoration of tissue architecture. In some tissues, stem cell populations contribute to regeneration, while in others a scar remains. Failure to resolve inflammation or excessive matrix deposition can lead to chronic wounds or fibrosis.
Key Genes Involved in GO:0042060 wound healing
The following genes and proteins are central to the cellular and molecular mechanisms of wound healing and are frequently studied using functional genomics approaches.
| Gene | Major Role | Research Relevance |
|---|---|---|
| COL1A1 | Major structural collagen in granulation tissue and scar | Target for knockout to assess matrix deposition and tensile strength |
| COL3A1 | Early collagen deposited in healing wounds | Knockout models to study collagen remodeling |
| FN1 | Provisional matrix protein that supports cell migration | Knockdown or knockout to test migration and adhesion |
| TGFB1 | Master cytokine driving fibroblast activation and collagen synthesis | Point mutations to dissect signaling in fibrosis |
| VEGFA | Key angiogenic factor promoting new blood vessel formation | Knockout or overexpression to study angiogenesis |
| PDGFB | Recruits fibroblasts and stimulates proliferation | Knock-in reporters to track cell recruitment |
| FGF2 | Promotes fibroblast and keratinocyte proliferation | Overexpression to enhance healing in models |
| MMP2 | Degrades collagen during remodeling | Knockout to assess matrix turnover |
| MMP9 | Degrades matrix and regulates inflammation | Knockout to study inflammatory resolution |
| TIMP1 | Inhibits MMP activity and stabilizes matrix | Overexpression to test fibrosis |
| ACTA2 | Marks myofibroblasts and drives wound contraction | Tagged knock-in for lineage tracing |
| KRT14 | Keratinocyte marker and structural protein in re-epithelialization | Knockout to study epidermal repair |
| HIF1A | Mediates hypoxia response and angiogenesis | Point mutation to test oxygen sensing |
| IL6 | Pro-inflammatory cytokine that modulates healing | Knockout to study inflammation phase |
| TNF | Pro-inflammatory cytokine with pleiotropic effects | Knockout or overexpression to dissect inflammation |
| CD68 | Macrophage marker | Reporter knock-in for immune cell tracking |
| PECAM1 | Endothelial cell marker for angiogenesis | Tagged knock-in for vessel imaging |
| VIM | Fibroblast marker and cytoskeletal protein | Knockout to study cell migration |
How Is wound healing Regulated?
Wound healing is regulated by a complex network of growth factors, cytokines, and mechanical cues. TGFB1 signaling through SMAD proteins is a central regulator of fibroblast activation and collagen deposition. VEGFA and HIF1A coordinate the angiogenic response to hypoxia in the wound bed. Inflammatory cytokines such as IL-6 and TNF modulate the transition from inflammation to proliferation, and their sustained elevation is associated with chronic wounds. Matrix metalloproteinases and their inhibitors (TIMPs) provide proteolytic control of matrix remodeling, and an imbalance in this system can lead to excessive degradation or fibrosis. Aging and nutritional status further modulate these regulatory pathways, affecting the speed and quality of repair.
wound healing and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TGFB1 | Fibrosis and hypertrophic scarring | Point mutation knock-in in fibroblasts |
| MMP9 | Chronic wounds with excessive matrix degradation | Knockout in keratinocytes or macrophages |
| VEGFA | Impaired angiogenesis in diabetic ulcers | Inducible overexpression in endothelial cells |
| HIF1A | Hypoxia response failure in chronic wounds | Point mutation to stabilize or destabilize protein |
| ACTA2 | Myofibroblast persistence in fibrosis | Tagged knock-in for lineage tracing |
Chronic Non-Healing Wounds
Chronic wounds, including diabetic ulcers, venous leg ulcers, and pressure sores, represent a failure of the normal healing sequence. They are characterized by persistent inflammation, impaired angiogenesis, and excessive matrix degradation, often driven by elevated MMPs and reduced growth factor activity. These wounds affect millions of patients worldwide and are a major cause of morbidity, especially in aging populations.
Fibrosis and Scarring
Excessive wound healing can lead to fibrosis and hypertrophic scarring, where myofibroblasts persist and deposit excessive collagen. TGFB1 and ACTA2 are key mediators of this pathological remodeling, and their dysregulation is implicated in fibrotic diseases of the skin, lung, liver, and kidney. Understanding the molecular switches that terminate healing is essential for anti-fibrotic therapy development.
Aging and Impaired Repair
Aging skin exhibits delayed wound healing due to reduced cell proliferation, altered immune responses, and diminished stem cell function. These changes increase susceptibility to chronic wounds and infections in older adults. Research into aging-related pathways in wound healing is therefore a growing area of geriatric medicine.
Microbial Influence and Probiotics
The wound microbiome can influence healing outcomes, with dysbiosis contributing to chronicity. Probiotic interventions have been explored as a means to modulate the wound environment and promote repair, although mechanisms remain under investigation.
From wound healing-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a candidate gene impair re-epithelialization? | Keratinocyte-specific knockout |
| Does a point mutation in a signaling gene alter fibroblast activation? | Point-mutation knock-in in fibroblasts |
| Can overexpression of a growth factor accelerate healing? | Inducible overexpression in skin models |
| How does a gene affect angiogenesis? | Endothelial cell knockout or knock-in |
| What is the lineage of myofibroblasts in fibrosis? | Tagged knock-in (e.g., ACTA2-reporter) |
| Does a gene regulate macrophage polarization? | Macrophage-specific knockout or overexpression |
How to Study the wound healing Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Excisional wound model | Rate of wound closure and tissue architecture | In vivo gene function studies |
| Scratch assay | Cell migration and proliferation | In vitro screening of healing genes |
| RNA-seq | Transcriptional changes during healing | Identification of pathways and biomarkers |
| Immunohistochemistry | Protein localization and cell types | Validation of gene expression in tissue |
| CRISPR screen | Genes required for cell migration or survival | Discovery of novel healing regulators |
| Proteomics | Protein abundance and modifications | Matrix and signaling analysis |
| Spatial transcriptomics | Gene expression in tissue context | Mapping healing zones |
In Vivo Wound Healing Models
Animal models, including excisional and incisional skin wound models in mice, are widely used to study the temporal phases of healing. These models allow assessment of re-epithelialization, granulation tissue formation, and angiogenesis through histological and immunohistochemical analyses. Genetic manipulation via CRISPR can be combined with these models to test gene function in vivo.
In Vitro Scratch and Migration Assays
Keratinocyte and fibroblast scratch assays measure cell migration and proliferation, which are essential for re-epithelialization and wound closure. These assays are amenable to high-throughput screening and gene editing to identify regulators of cell motility.
Molecular and Omics Approaches
RNA sequencing, proteomics, and spatial transcriptomics can profile gene expression changes across healing phases. These methods help identify novel regulators and biomarkers of wound healing and are often combined with CRISPR screens to establish causality.
Imaging and Histology
Immunofluorescence and immunohistochemistry for markers such as KRT14, ACTA2, CD68, and PECAM1 allow visualization of re-epithelialization, myofibroblast differentiation, macrophage infiltration, and angiogenesis in tissue sections.
How CRISPR Can Be Used to Study GO:0042060 wound healing
Knockout
CRISPR knockout is used to delete candidate wound healing genes in keratinocytes, fibroblasts, or endothelial cells to assess their requirement for migration, proliferation, and matrix production. For example, knockout of COL1A1 or FN1 can reveal defects in matrix deposition and wound closure.
Point Mutation
Point mutations can be introduced to model specific amino acid changes in signaling proteins such as TGFB1 or HIF1A, allowing dissection of phosphorylation sites or binding interfaces that regulate healing responses.
Knock-in
Knock-in of reporter genes or tags (e.g., fluorescent proteins) into endogenous loci such as ACTA2 or PECAM1 enables lineage tracing and live imaging of myofibroblasts and endothelial cells during wound healing.
Overexpression
Overexpression of growth factors like VEGFA or FGF2 via CRISPR-mediated knock-in of a strong promoter can test whether enhanced expression accelerates healing or induces fibrosis in preclinical models.
How EDITGENE Supports wound healing Research
Researchers studying wound healing-related genes often need to determine whether a candidate gene is causally involved in repair or simply correlated with the process. Establishing causality requires precise genetic manipulation in relevant cell types, followed by functional assays that measure migration, proliferation, matrix production, and angiogenesis. EDITGENE provides a comprehensive suite of CRISPR services to support these investigations, from knockout to knock-in and library screening.
Contact EDITGENE today to design your custom CRISPR model for wound healing research.
Frequently Asked Questions About wound healing
What is GO:0042060 wound healing?
GO:0042060 is the Gene Ontology term for the biological process that restores tissue integrity after injury, encompassing hemostasis, inflammation, proliferation, and remodeling.
What genes are involved in wound healing?
Key genes include COL1A1, COL3A1, FN1, TGFB1, VEGFA, PDGFB, MMP2, MMP9, TIMP1, ACTA2, KRT14, and HIF1A, among others.
What are the phases of wound healing?
The main phases are hemostasis, inflammation, proliferation, and remodeling, each with distinct cellular and molecular events.
How is wound healing studied in the lab?
Common methods include in vivo wound models, in vitro scratch assays, RNA-seq, proteomics, and immunohistochemistry for markers like KRT14 and ACTA2.
What happens when wound healing goes wrong?
Dysregulation can lead to chronic non-healing wounds, fibrosis, or excessive scarring, often involving persistent inflammation and matrix imbalance.
Can CRISPR be used to study wound healing?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to test gene function in wound healing research.
What is the role of fibroblasts in wound healing?
Fibroblasts produce extracellular matrix, migrate into the wound, and can differentiate into myofibroblasts that contract the wound and form scar tissue.
How does aging affect wound healing?
Aging impairs healing through reduced cell proliferation, altered immune responses, and diminished stem cell function, increasing the risk of chronic wounds.
Does nutrition influence wound healing?
Yes, adequate protein, vitamins, and minerals are required for optimal healing, and nutritional deficiencies can delay repair.
What are potential therapeutic targets in wound healing?
TGFB1, VEGFA, MMPs, and their regulators are among the most studied targets for modulating healing and fibrosis.
Conclusion
GO:0042060 wound healing is a fundamental biological process that integrates multiple cell types, signaling pathways, and matrix remodeling events to restore tissue integrity after injury. Its dysregulation contributes to chronic wounds, fibrosis, and impaired regeneration, making it a critical area of biomedical research. Advances in CRISPR-based genome editing and functional genomics now allow researchers to systematically test the role of individual genes in healing, accelerating the discovery of therapeutic targets. Continued investigation into the molecular mechanisms of wound healing promises to improve outcomes for patients with acute and chronic wounds.
References
- 1. Wilkinson HN et al.. 2020. Wound healing: cellular mechanisms and pathological outcomes.. Open Biol 10(9):200223 PMID: 32993416
- 3. Velnar T et al.. 2009. The wound healing process: an overview of the cellular and molecular mechanisms.. J Int Med Res 37(5):1528-42 PMID: 19930861
- 4. Ghaly P et al.. 2021. The role of nutrition in wound healing: an overview.. Br J Nurs 30(5):S38-S42 PMID: 33733851
- 5. Han G et al.. 2017. Chronic Wound Healing: A Review of Current Management and Treatments.. Adv Ther 34(3):599-610 PMID: 28108895
- 6. Bădăluță VA et al.. 2024. Probiotics in Wound Healing.. Int J Mol Sci 25(11) PMID: 38891909
- 7. Kremer M et al.. 2024. Aging Skin and Wound Healing.. Clin Geriatr Med 40(1):1-10 PMID: 38000854
- 8. Bainbridge P. 2013. Wound healing and the role of fibroblasts.. J Wound Care 22(8):407-8, 410-12 PMID: 23924840
